Search - tctmd.com

Displaying 81 - 100 of 140

Sort: Relevancy | Date

Presentation NY Valves 2024

TELLTALE for TAV-in-SAV or TAV-in-Native

Presenter: Toby Rogers

June 06, 2024

Presentation NY Valves 2024

BASILICA or ShortCut for TAV-in-SAVR or TAV-in-TAV

Presenter: Philippe Genereux

June 06, 2024

Presentation NY Valves 2024

The Use of Shockwave in Severely Calcified Ostial Left Subclavian Stenosis

Presenter: Elsa Hebbo

June 06, 2024

Presentation NY Valves 2024

RAVR or TAVR as an Interventional Cardiologist – My Clinical Decision Making

Presenter: Ramesh Daggubati

June 06, 2024

Presentation NY Valves 2024

Ascending Aortic Aneurysm Treated With Conformable Thoracic Stent Graft

Presenter: Muhammad Jafar Khan

June 06, 2024

Presentation NY Valves 2024

Is Leaflet Modification Sufficient to Prevent Coronary Obstruction - When to Consider Snorkel Stenting

Presenter: Antonio Mangieri

June 06, 2024

Presentation NY Valves 2024

The 2024 'Toolbox' for Leaflet Modification in TAVR

Presenter: Jaffar M. Khan

June 06, 2024

Presentation NY Valves 2024

Can TAV-in-TAV Simulations be Useful in Procedural Planning?

Presenter: Vinod H. Thourani

June 06, 2024

Presentation NY Valves 2024

How to Interpret the Pathology Data From TAVR Explants

Presenter: Stephanie Sellers

June 06, 2024

Presentation NY Valves 2024

The Future is Now! TAVR is a Favorable Alternative in AS Patients Under 65 Years Old

Presenter: Bernard Prendergast

June 06, 2024

Presentation NY Valves 2024

SAVR is Clearly the Gold Standard in AS Patients Under 65 Years Old

Presenter: Keith B. Allen

June 06, 2024

Presentation NY Valves 2024

TAVR in Young Patients - Current Treatment Patterns in the US

Presenter: Mayra Guerrero

June 06, 2024

News Conference News NY Valves 2024

Long-term Mortality After TAVI Lower With DOACs vs VKAs

Todd Neale

June 06, 2024

Presentation NY Valves 2024

Transcatheter Valve Selection for Revalving and Overview of European Trials

Presenter: Radoslaw Parma

June 06, 2024

Presentation NY Valves 2024

Introduction to the Redo TAVR App: Comprehensive Diagnosis and Procedure Planning

Presenter: Vinayak N. Bapat

June 06, 2024

Presentation NY Valves 2024

The Coronary Access Conundrum in Revalving Strategies

Presenter: Giuseppe Tarantini

June 06, 2024

Presentation NY Valves 2024

Projecting the Frequency of Failed Transcatheter Aortic Valves

Presenter: Philippe Genereux

June 06, 2024

Presentation NY Valves 2024

In younger patients receiving TAVR: why does the first intervention matter?

Presenter: Vinod H. Thourani

June 06, 2024

Presentation NY Valves 2024

Mid-term outcomes of balloon expandable TAVR: do gradients and gender matter?

Presenter: Rebecca T. Hahn

June 06, 2024

News Conference News NY Valves 2024

Essentials for 3D-ICE in Structural Interventions Explored in Position Statement

Caitlin E. Cox

June 06, 2024

Advertisement

TELLTALE for TAV-in-SAV or TAV-in-Native

BASILICA or ShortCut for TAV-in-SAVR or TAV-in-TAV

The Use of Shockwave in Severely Calcified Ostial Left Subclavian Stenosis

RAVR or TAVR as an Interventional Cardiologist – My Clinical Decision Making

Ascending Aortic Aneurysm Treated With Conformable Thoracic Stent Graft

Is Leaflet Modification Sufficient to Prevent Coronary Obstruction - When to Consider Snorkel Stenting

The 2024 'Toolbox' for Leaflet Modification in TAVR

Can TAV-in-TAV Simulations be Useful in Procedural Planning?

How to Interpret the Pathology Data From TAVR Explants

The Future is Now! TAVR is a Favorable Alternative in AS Patients Under 65 Years Old

SAVR is Clearly the Gold Standard in AS Patients Under 65 Years Old

TAVR in Young Patients - Current Treatment Patterns in the US

Long-term Mortality After TAVI Lower With DOACs vs VKAs

Transcatheter Valve Selection for Revalving and Overview of European Trials

Introduction to the Redo TAVR App: Comprehensive Diagnosis and Procedure Planning

The Coronary Access Conundrum in Revalving Strategies

Projecting the Frequency of Failed Transcatheter Aortic Valves

In younger patients receiving TAVR: why does the first intervention matter?

Mid-term outcomes of balloon expandable TAVR: do gradients and gender matter?

Essentials for 3D-ICE in Structural Interventions Explored in Position Statement

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content